ExoCoBio lands $11 mln Series A
South Korea-based ExoCoBio Inc, a developer of exosome-based cosmeceuticals and biopharmaceuticals for skin and tissue regeneration, has secured $11 million in its Series A funding. The investors included SBI Investment, Atinum Investment, ID Ventures and Dt&Investment.
3 May 2017•1 min read
